SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-23-129003
Filing Date
2023-12-26
Accepted
2023-12-26 08:12:57
Documents
6
Period of Report
2023-12-26

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2333691d1_6k.htm 6-K 47794
2 EXHIBIT 2.1 tm2333691d1_ex2-1.htm EX-2.1 850068
3 EXHIBIT 99.1 tm2333691d1_ex99-1.htm EX-99.1 76049
4 EXHIBIT 99.2 tm2333691d1_ex99-2.htm EX-99.2 24817
5 EXHIBIT 99.3 tm2333691d1_ex99-3.htm EX-99.3 12026
6 EXHIBIT 99.4 tm2333691d1_ex99-4.htm EX-99.4 20074
  Complete submission text file 0001104659-23-129003.txt   1031929
Mailing Address BUILDING 3, 418 GUILIN ROAD XUHUI DISTRICT SHANGHAI F4 200030
Business Address BUILDING 3, 418 GUILIN ROAD XUHUI DISTRICT SHANGHAI F4 200030 00862164031522
Gracell Biotechnologies Inc. (Filer) CIK: 0001826492 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39838 | Film No.: 231511394
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)